| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.096 | 0.6 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.085 | 0.6 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |